Trifecta Clinical, one of the largest global providers of online clinical training solutions, recently joined the Board of Directors for the Asia Training Consortium (ATC). The ATC is a group of pharmaceutical companies, clinical research organizations and regional associations, which has pooled resources to deliver quality training courses for the development of clinical research professionals in the Asia Pac region.

“We’re thrilled to be a part of an organization that is meeting an acute need in clinical development in Asia,” says Trifecta Clinical CEO Dave Young. “Our technology and training experience complements the strong industry partners who make up the ATC.”

There is a great need in this region for additional qualified personnel in medical research. In China alone, the number of clinical research associates (professionals who ensure protocols and Good Clinical Practices are followed in clinical trials) must double every two years to keep up with demand.

“Trifecta has a track record of effectively delivering clinical training around the world,” says ATC Board Chairman John Constantine, who also serves as the Executive Director and Dean of the Merck Polytechnic Institute. “They have the ability to provide a very quick start-up program on a platform that the ATC can continue to grow with as we help meet Asia’s rapidly increasing needs. As a technology company, Trifecta rounds out our Board’s membership.”

Trifecta has developed an application platform purpose-built for training and managing clinical research sites. Trifecta will leverage this expertise for the ATC by providing training to future members of the clinical research community. Trifecta is also sponsoring a working group to create an open Extensible Markup Language (XML) standard for exchanging clinical training information – Clinical Training Interoperability Open Standard (CTIOS). The creation of this open standard will allow authorized organizations to easily communicate training status in compliance with privacy regulations and security best practices.

“By sponsoring this working group, we hope to serve as a catalyst to accelerate the vision of the ATC,” says Young. “Once the working group membership is in place, we will work together to release a draft standard for comment and evaluation.”

Trifecta joins Covance and Novartis as the three non-permanent member organizations serving a three-year term. The six permanent member organizations are Merck, Pfizer, Bayer, RPS, Orchestrall and the Pan-Asian Clinical Research Association (PACRA).

To learn more about Trifecta or the ATC, visit Trifecta's booth at the 9th Drug Information Association (DIA) Japan Annual Meeting in Tokyo on November 19-21 at the Toshi Center Hotel.

About Trifecta Clinical

Trifecta Clinical is a global leader in online investigator training. Founded in 2004, Trifecta Clinical’s solutions have been proven to decrease timelines for site readiness, accelerate enrollment and improve communication between sponsors, sites and clinical research associates on hundreds of clinical trials.